P50 OVERALL SURVIVAL ADVANTAGE OF MONOCLONAL ANTIBODIES BASED-TREATMENTS IN MULTIPLE MYELOMA PATIENTS RELAPSED AFTER ALLOGENEIC STEM CELL TRANSPLANTATION

C. Nozzoli, M. Pucillo, M. Martino, L. Giaccone, A. Rambaldi, E. Benedetti, D. Russo, N. Mordini, P. Bernasconi, S. Mangiacavalli, P. Pioltelli, P. Carluccio, P. Galieni, M. Ladetto, S. Sica, M. Isola, M. De Martino, E. Oldani, E. Degrandi, A. Biasco, R. Fanin, R. Saccardi, F. Ciceri, F. Patriarca, on behalf of the Gruppo Italiano Trapianto Midollo Osseo (GITMO)

Open source

DOI: 10.1097/01.hs9.0000936328.14674.49
Published: 5
Container: HemaSphere
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/01.hs9.0000936328.14674.49,
  title = {P50 OVERALL SURVIVAL ADVANTAGE OF MONOCLONAL ANTIBODIES BASED-TREATMENTS IN MULTIPLE MYELOMA PATIENTS RELAPSED AFTER ALLOGENEIC STEM CELL TRANSPLANTATION},
  author = {C. Nozzoli and M. Pucillo and M. Martino and L. Giaccone and A. Rambaldi and E. Benedetti and D. Russo and N. Mordini and P. Bernasconi and S. Mangiacavalli and P. Pioltelli and P. Carluccio and P. Galieni and M. Ladetto and S. Sica and M. Isola and M. De Martino and E. Oldani and E. Degrandi and A. Biasco and R. Fanin and R. Saccardi and F. Ciceri and F. Patriarca and on behalf of the Gruppo Italiano Trapianto Midollo Osseo (GITMO)},
  year = {2023},
  journal = {HemaSphere},
  doi = {10.1097/01.hs9.0000936328.14674.49},
  url = {https://doi.org/10.1097/01.hs9.0000936328.14674.49}
}

RIS

TY  - JOUR
TI  - P50 OVERALL SURVIVAL ADVANTAGE OF MONOCLONAL ANTIBODIES BASED-TREATMENTS IN MULTIPLE MYELOMA PATIENTS RELAPSED AFTER ALLOGENEIC STEM CELL TRANSPLANTATION
AU  - C. Nozzoli
AU  - M. Pucillo
AU  - M. Martino
AU  - L. Giaccone
AU  - A. Rambaldi
AU  - E. Benedetti
AU  - D. Russo
AU  - N. Mordini
AU  - P. Bernasconi
AU  - S. Mangiacavalli
AU  - P. Pioltelli
AU  - P. Carluccio
AU  - P. Galieni
AU  - M. Ladetto
AU  - S. Sica
AU  - M. Isola
AU  - M. De Martino
AU  - E. Oldani
AU  - E. Degrandi
AU  - A. Biasco
AU  - R. Fanin
AU  - R. Saccardi
AU  - F. Ciceri
AU  - F. Patriarca
AU  - on behalf of the Gruppo Italiano Trapianto Midollo Osseo (GITMO)
PY  - 2023
JO  - HemaSphere
DO  - 10.1097/01.hs9.0000936328.14674.49
UR  - https://doi.org/10.1097/01.hs9.0000936328.14674.49
ER  -

APA

Nozzoli, C., Pucillo, M., Martino, M., Giaccone, L., Rambaldi, A., Benedetti, E., Russo, D., Mordini, N., Bernasconi, P., Mangiacavalli, S., Pioltelli, P., Carluccio, P., Galieni, P., Ladetto, M., Sica, S., Isola, M., Martino, M. D., Oldani, E., Degrandi, E., Biasco, A., Fanin, R., Saccardi, R., Ciceri, F., Patriarca, F., & (GITMO), O. B. O. T. G. I. T. M. O. (2023). P50 OVERALL SURVIVAL ADVANTAGE OF MONOCLONAL ANTIBODIES BASED-TREATMENTS IN MULTIPLE MYELOMA PATIENTS RELAPSED AFTER ALLOGENEIC STEM CELL TRANSPLANTATION. HemaSphere. https://doi.org/10.1097/01.hs9.0000936328.14674.49

Source records

doaj · retrieved 2026-09-26T02:14:03.448Z